Skip to main content
. 2018 May 31;38(3):174–180. doi: 10.5144/0256-4947.2018.174

Table 1.

Baseline characteristics.

Stage 1 Without ECMO (n=9) Stage 2 With ECMO (n=14) P

Male 0 (0.0) 4 (28.6) .127
Mean age (years) 65.4 (14.8) 53.6 (17.7) .110
BMI 25.1 (3.1) 26.0 (4.4) .577
Smoking 0 (0.0) 4 (28.6) .127
DM 2 (22.2) 2 (14.3) >.999
Hypertension 4 (44.4) 3 (21.4) .363
Cancer 2 (22.2) 0 (0.0) .142
Predisposing factor
Post orthopedic surgery 6 (66.7) 3 (21.4) .077
Immobility 3 (33.3) 5 (35.7) >.999
Previous DVT 1 (11.1) 0 (0.0) .391
Trauma 0 (0.0) 2 (14.3) .502
Cancer 2 (22.2) 0 (0.0) .142
Unknown 0 (0.0) 3(21.4) .253
TTE parameter
RVSP 35.1 (28.4) 42.9 (13.3) .455
TAPSE 6.3 (6.2) 11.9 (4.3) .027
RV dilation 7 (77.8) 13 (92.9) .538
Chest CT finding
Proximal PE 3 (33.3) 12 (85.7) .023
Cardiac arrest
IHCA 7 (77.8) 7 (50.0) .228
OHCA 1 (11.1) 4 (28.6) .611
Cardiogenic shock 1 (11.1) 3 (21.4) >.999
Treatment
Heparin 2 (22.2) 13 (92.9) .001
LMWH 2 (22.2) 0 (0.0) .142
Urokinase 4 (44.4) 1 (7.1) .056
tPA 1 (11.1) 0 (0.0) .391
Surgical embolectomy 0 (0.0) 1 (7.1) >.999
ECG finding
Asystole 2 (22.2) 4 (28.6) >.999
PEA 5 (55.6) 5 (35.7) .417
VT/V.fib 1 (11.1) 2 (14.3) >.999
Sinus tachycardia 1 (11.1) 3 (21.4) >.999
GCS 11.1 (5.6) 6.3 (4.1) .056
APACHE II score 22.1 (10.8) 22.4 (6.9) .932
Laboratory finding at cardiogenic shock
pH 7.2 (0.3) 7.2 (0.2) .972
HCO3 (mmol/L) 14.7 (5.7) 12.6 (3.1) .281
Potassium (mEq/L) 4.3 (0.9) 4.0 (0.9) .466
Creatinine (mg/dL) 1.6 (1.3) 1.3 (0.7) .526
Platelet (×109/L) 183.0 (86.9) 175.4 (83.7) .841
D-dimer 3.4 (1.7) 11.6 (12.9) .148
CK-MB (ng/mL) 13.1 (14.8) 6.5 (5.9) .125
Death in hospital 7 (77.8) 8 (57.1) .400

Data are expressed as mean(standard deviation) or N (%); ECMO, extracorporeal membrane oxygenation; BMI, body mass index; DM, diabetes mellitus; DVT, deep vein thrombosis; TTE, trans-thoracic echocardiography; RVSP, right ventricular systolic pressure; TAPSE, tricuspid annular plane systolic excursion; RV, right ventricle; CT, computed tomography; PE, pulmonary embolism; IHCA, in-hospital cardiac arrest; OHCA, out of hospital cardiac arrest; LMWH, low molecular weight heparin; tPA, tissue plasminogen activator; ECG, electrocardiography; PEA, pulseless electrical activity; VT, ventricular tachycardia; V.fib, ventricular fibrillation; GCS, Glasgow Coma Scale; APACHE II, Acute Physiology and Chronic Health Evaluation II; CK-MB, creatine kinase MB.